Abstract: Compound are provided which can inhibit ERK5. Also provided are pharmaceutical compositions and medical uses of the same, including the use in treating or preventing conditions such as cancers.
| # | Name | Date |
|---|---|---|
| 1 | 202517013971-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [18-02-2025(online)].pdf | 2025-02-18 |
| 2 | 202517013971-STATEMENT OF UNDERTAKING (FORM 3) [18-02-2025(online)].pdf | 2025-02-18 |
| 3 | 202517013971-REQUEST FOR EXAMINATION (FORM-18) [18-02-2025(online)].pdf | 2025-02-18 |
| 4 | 202517013971-FORM 18 [18-02-2025(online)].pdf | 2025-02-18 |
| 5 | 202517013971-FORM 1 [18-02-2025(online)].pdf | 2025-02-18 |
| 6 | 202517013971-DECLARATION OF INVENTORSHIP (FORM 5) [18-02-2025(online)].pdf | 2025-02-18 |
| 7 | 202517013971-COMPLETE SPECIFICATION [18-02-2025(online)].pdf | 2025-02-18 |
| 8 | 202517013971-Proof of Right [13-05-2025(online)].pdf | 2025-05-13 |
| 9 | 202517013971-FORM-26 [13-05-2025(online)].pdf | 2025-05-13 |
| 10 | 202517013971-FORM 3 [13-05-2025(online)].pdf | 2025-05-13 |